Stay updated with breaking news from Philip Low. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US CLOSED 6 BILLION DOLLAR SERIES B DEAL GlobeNewswire April 05, 2024 SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBrain™ Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of...
It was a busy year for the Indiana life sciences community, with a flurry of billion-dollar deals, major announcements, and a few setbacks. Here we present the top 10 stories of 2023—the good, the bad and the ugly—about an industry that is often hailed as a key driver of Indiana’s economy.
With this new round of funding, he says they’re now closer than they’ve ever been to helping save lives in developing countries.
Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reduced...
Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reduced Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry in the College of Science Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry in the College of Science, has been awarded $1.38 million from Open Phila